These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30297617)

  • 1. Pain in Mucopolysaccharidoses: Analysis of the Problem and Possible Treatments.
    Congedi S; Orzalesi M; Di Pede C; Benini F
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy in mucopolysaccharidosis disorders.
    Scarpa M; Lourenço CM; Amartino H
    Mol Genet Metab; 2017 Dec; 122S():55-61. PubMed ID: 29170080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical management of behavioral problems in mucopolysaccharidoses disorders.
    Escolar ML; Jones SA; Shapiro EG; Horovitz DDG; Lampe C; Amartino H
    Mol Genet Metab; 2017 Dec; 122S():35-40. PubMed ID: 29170079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ENT and mucopolysaccharidoses.
    Bianchi PM; Gaini R; Vitale S
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):127. PubMed ID: 30442170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidoses.
    Cimaz R; La Torre F
    Curr Rheumatol Rep; 2014 Jan; 16(1):389. PubMed ID: 24264718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of brain disease in the mucopolysaccharidoses.
    Scarpa M; Orchard PJ; Schulz A; Dickson PI; Haskins ME; Escolar ML; Giugliani R
    Mol Genet Metab; 2017 Dec; 122S():25-34. PubMed ID: 29153844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and potential therapeutic strategies for mucopolysaccharidoses.
    Noh H; Lee JI
    J Clin Pharm Ther; 2014 Jun; 39(3):215-24. PubMed ID: 24612142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Manifestations of Mucopolysaccharidoses.
    Tran MC; Lam JM
    Pediatr Dermatol; 2016 Nov; 33(6):594-601. PubMed ID: 27601403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.
    Minami K; Morimoto H; Morioka H; Imakiire A; Kinoshita M; Yamamoto R; Hirato T; Sonoda H
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology, evaluation, and management of sleep disorders in the mucopolysaccharidoses.
    Rapoport DM; Mitchell JJ
    Mol Genet Metab; 2017 Dec; 122S():49-54. PubMed ID: 28964643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Otorhinolaryngological manifestations of the mucopolysaccharidoses.
    Simmons MA; Bruce IA; Penney S; Wraith E; Rothera MP
    Int J Pediatr Otorhinolaryngol; 2005 May; 69(5):589-95. PubMed ID: 15850680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of metabolic inflammation.
    Opoka-Winiarska V; Jurecka A; Emeryk A; Tylki-Szymańska A
    Osteoarthritis Cartilage; 2013 Dec; 21(12):1813-23. PubMed ID: 23954699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular features in mucopolysaccharidosis: diagnosis and treatment.
    Del Longo A; Piozzi E; Schweizer F
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):125. PubMed ID: 30442167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glaucoma in mucopolysaccharidoses.
    Kong W; Zhang J; Lu C; Ding Y; Meng Y
    Orphanet J Rare Dis; 2021 Jul; 16(1):312. PubMed ID: 34266471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucopolysaccharidoses: advances in medical care lead to challenges in orthopaedic surgical care.
    Williams N; Challoumas D; Ketteridge D; Cundy PJ; Eastwood DM
    Bone Joint J; 2017 Sep; 99-B(9):1132-1139. PubMed ID: 28860391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucopolysaccharidosis and organ of sight].
    Modrzejewska M; Kot J; Wiśniewska A; Romanowska H; Gizewska M
    Klin Oczna; 2013; 115(2):152-7. PubMed ID: 24059034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations for Evaluation and Management of Pain in Patients With Mucopolysaccharidosis in Latin America.
    Politei JM; Gordillo-González G; Guelbert NB; de Souza CFM; Lourenço CM; Solano ML; Junqueira MM; Magalhães TSPC; Martins AM
    J Pain Symptom Manage; 2018 Jul; 56(1):146-152. PubMed ID: 29649527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists.
    Boffi L; Russo P; Limongelli G
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):122. PubMed ID: 30442163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations - Neurological signs and symptoms.
    Shapiro EG; Jones SA; Escolar ML
    Mol Genet Metab; 2017 Dec; 122S():1-7. PubMed ID: 29074036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.